The average weight loss with Retatrutide exceeds 24%, meaning most users achieve cardiovascular risk reduction that would typically require multiple interventions
( Excellent discussion of the challenges of conducting clinical trials in obesity ) Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP, SCALE Obesity and Prediabetes NN8022-1839 Study Group
list as of April 2026, per manufacturer published pricing
Semaglutide helps boost your satiety while controlling your appetite, helping you feel more satisfied and full with smaller amounts of food
[17] [15] For those using GLP-1 medications for diabetes management , discontinuation often results in worsening glycaemic control